DU004ZZ
Beam Radiation Ovary to None with None, Heavy Particles (Protons,Ions) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | U Female Reproductive System |
| Operation | 0 Beam Radiation |
| Body Part | 0 Ovary |
| Approach | 4 Heavy Particles (Protons,Ions) |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation for the female reproductive system directs radiation from a machine outside the body - typically a linear accelerator - through the skin and surrounding tissue to reach a tumor in the uterus, cervix, ovary, vagina, or vulva. The beams are shaped and aimed from multiple angles so they overlap at the tumor site, concentrating the dose there while spreading a lower dose across the tissue the beams pass through on the way in.
This approach is a mainstay for cervical and endometrial cancers, often given over several weeks in a series of daily sessions, and is frequently paired with brachytherapy for cervical cancer to boost the dose to the tumor bed beyond what external beams alone can safely deliver. It's also used for vaginal and vulvar cancers, and sometimes as palliative treatment to shrink a tumor causing pain, bleeding, or obstruction when cure isn't the goal.
Treatment planning involves imaging to map the tumor and surrounding organs at risk, such as the bladder and rectum, so the radiation field can be shaped to limit exposure to those structures while still covering the target with an adequate margin.
Anatomy & Axis Detail
Ovary
The ovaries are paired glands responsible for oocyte production and hormone synthesis, positioned within the pelvis where their mobility and proximity to bowel and ureter make external beam planning technically demanding. Beam radiation to the ovary is uncommon as a primary treatment, since ovarian malignancies are more often managed surgically and with chemotherapy, but external fields may be used for radiosensitive tumor types, for palliation of pelvic recurrence, or as part of whole-abdominal or pelvic radiation fields that encompass the ovary. Because ovarian tissue is highly sensitive to radiation and its loss ends reproductive and hormonal function, treatment planning in patients of reproductive age often involves careful field shaping or prior surgical transposition of the ovaries outside the intended field to preserve function when clinically appropriate.
Modality Qualifier: Heavy Particles (Protons,Ions)
Heavy Particles (Protons, Ions) covers particle-beam radiotherapy using protons or heavier charged ions, which exhibit a Bragg peak that concentrates dose at a specific depth with minimal exit dose beyond the target. This property distinguishes it from conventional photon or electron beams, which continue to deposit dose along their path, and makes heavy particle therapy attractive for tumors near critical structures like the spinal cord or optic pathways.
Coding & Documentation
Coding requires documentation of the specific reproductive structure treated - uterus, cervix, ovary, vagina, or vulva each has its own body part value - along with confirmation that the source was external to the body, which is what defines this root operation. The qualifier for the type of radiation modality or energy source, where captured, should also be reflected if the facility's documentation supports that level of detail.
A common assignment mistake is coding the treatment site based on the underlying cancer diagnosis rather than the actual treatment field documented by radiation oncology - a cervical cancer patient may also receive beam radiation to nodal or pelvic regions rather than the cervix as coded, so the note needs to state where the beam was actually directed. Coders should also avoid conflating a planning or simulation session with an actual treatment delivery, since only the latter supports code assignment.